List view / Grid view
18 June 2012 | By ALM Communications Inc.
USON, announces the appointment of an award-winning veteran of the automated instrumentation industry, Charles D. Foran Jr. (Dave), as USON President...
Lonza, a global leader in the field of biologics manufacturing, today announced the successful completion of its new GMP clean room within its Houston, Texas operations. The clean room supports multiple types of viral vector and viral vaccine projects, with working volumes up to 2,000 liters.
15 June 2012 | By Merck
"While we are pleased with the court's ruling that the patent for NASONEX is valid..."
15 June 2012 | By GlaxoSmithKline
GSK has received a renewed invitation from Human Genome Sciences’...
15 June 2012 | By Roche
Over 20,000 employees of Roche marked the International Day of the African Child...
15 June 2012 | By Pfizer
Pfizer has announced the launch of a new Web site, “Campaign Against Migraine”, to help migraine sufferers across the country...
14 June 2012 | By GlaxoSmithKline
First combination vaccine to help prevent meningococcal serogroups C and Y and Hib disease...
14 June 2012 | By Teva Pharmaceutical Industries Ltd
Teva announced positive top-line results from the GALA Phase III clinical trial assessing the efficacy, safety and tolerability...
14 June 2012 | By H. Lundbeck A/S
Lundbeck proposes to restructure its commercial organisation in Europe to build a more flexible commercial infrastructure and to maintain cost control...
13 June 2012 | By Alto Marketing
Speeding up research with novel cell manipulation and analysis platforms...
13 June 2012 | By kdm communications limited
Syrris becomes the leading supplier of flow chemistry solutions around the world...
Five Prime Therapeutics, Inc. (“FivePrime”) has entered into research and commercial agreements with BioWa, Inc. and Lonza to use their POTELLIGENT® CHOK1SV Cell Line for the research, development and production of multiple proprietary antibodies in FivePrime’s oncology pipeline.
13 June 2012 | By Novo Nordisk
Focus will be on disease-modifying immunotherapies for type 1 diabetes...
13 June 2012 | By Sanofi
Sanofi granted the award for “Leading Pan-European Quoted Company for Investor Relations”...
13 June 2012 | By Merck
New data from two pivotal Phase III trials...
